Brazil s Anvisa rejects bid to import Bharat Biotech vaccine 10 Apr 2021 / 08:59 H.
SAO PAULO, March 31 (Reuters) - Brazilian health regulator Anvisa on Wednesday rejected a request from the government to import doses of Covaxin, the COVID-19 vaccine developed by Indian laboratory Bharat Biotech, citing a lack of safety data and documentation. The importer did not present all the documents required by law, said Anvisa board member Alex Machado Campos.
The Brazilian government signed a contract last month to buy 20 million doses of Covaxin and Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
However, Anvisa said the vaccine did not meet its manufacturing standards.
Brazil s Anvisa rejects bid to import Bharat Biotech vaccine Reuters 19 hrs ago
SAO PAULO, March 31 (Reuters) - Brazilian health regulator Anvisa on Wednesday rejected a request from the government to import doses of Covaxin, the COVID-19 vaccine developed by Indian laboratory Bharat Biotech, citing a lack of safety data and documentation. The importer did not present all the documents required by law, said Anvisa board member Alex Machado Campos.
The Brazilian government signed a contract last month to buy 20 million doses of Covaxin and Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
However, Anvisa said the vaccine did not meet its manufacturing standards.
Brazil s Anvisa rejects bid to import Bharat Biotech vaccine | WSAU News/Talk 550 AM · 99 9 FM wsau.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsau.com Daily Mail and Mail on Sunday newspapers.